EICHORCondition: Pneumococcal Vaccines · Sponsor: Vaxcyte, Inc.
This is a Phase 3, randomized, double-blind study to evaluate the safety and immunogenicity of VAX-31 and seasonal influenza vaccine in pneumococcal-naïve adults ≥ 50 years when the two vaccines are administered at the same visit or separately.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Hope Research Institute | Phoenix, Arizona, United States | — |
| Tekton Research at Fort Collins | Fort Collins, Colorado, United States | — |
| University Clinical Research - Deland | DeLand, Florida, United States | — |
| CenExel Research Centers of America | Hollywood, Florida, United States | — |
| Health Awareness | Jupiter, Florida, United States | — |
| Accel Research Sites - Lakeland | Lakeland, Florida, United States | — |
| Accel Research Sites - Largo | Largo, Florida, United States | — |
| Precision Clinical Research | Sunrise, Florida, United States | — |
| Velocity Valparaiso | Valparaiso, Indiana, United States | — |
| Johnson County ClinTrials | Lenexa, Kansas, United States | — |
| AMR Lexington | Lexington, Kentucky, United States | — |
| DM Clinical Research - Detroit | Detroit, Michigan, United States | — |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07365826